Biogen (BIIB)
(Delayed Data from NSDQ)
$217.51 USD
+4.00 (1.87%)
Updated May 3, 2024 04:00 PM ET
After-Market: $219.25 +1.74 (0.80%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/23/24 |
---|---|
Current Quarter | 3.97 |
EPS Last Quarter | 3.67 |
Last EPS Surprise | 6.38% |
ABR | 1.68 |
Earnings ESP
|
0.02% |
---|---|
Current Year | 15.60 |
Next Year | 17.56 |
EPS (TTM) | 15.00 |
P/E (F1) | 13.94 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.38B | 2.41B | 9.52B | 9.54B |
# of Estimates | 26 | 26 | 27 | 27 |
High Estimate | 2.47B | 2.50B | 9.76B | 10.37B |
Low Estimate | 2.32B | 2.25B | 9.17B | 8.62B |
Year ago Sales | 2.46B | 2.53B | 9.84B | 9.52B |
Year over Year Growth Est. | -2.97% | -4.86% | -3.16% | 0.21% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.97 | 4.02 | 15.60 | 17.56 |
# of Estimates | 25 | 24 | 27 | 27 |
Most Recent Consensus | 3.82 | 3.98 | 15.85 | 16.65 |
High Estimate | 6.04 | 4.27 | 16.37 | 21.11 |
Low Estimate | 3.40 | 3.01 | 15.10 | 13.75 |
Year ago EPS | 4.02 | 4.36 | 14.72 | 15.60 |
Year over Year Growth Est. | -1.24% | -7.80% | 5.98% | 12.59% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 0 | 1 |
Up Last 30 Days | 8 | 9 | 16 | 7 |
Up Last 60 Days | 8 | 9 | 16 | 7 |
Down Last 7 Days | 0 | 1 | 1 | 0 |
Down Last 30 Days | 12 | 11 | 5 | 12 |
Down Last 60 Days | 12 | 11 | 6 | 14 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 3.97 | 4.02 | 15.60 | 17.56 |
7 Days Ago | 3.96 | 4.02 | 15.60 | 17.56 |
30 Days Ago | 3.97 | 4.02 | 15.48 | 17.67 |
60 Days Ago | 3.97 | 4.02 | 15.49 | 17.72 |
90 Days Ago | 3.92 | 4.21 | 15.73 | 19.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.97 | 4.00 | 15.64 | 17.01 |
Zacks Consensus Estimate | 3.97 | 4.02 | 15.60 | 17.56 |
Earnings ESP | 0.02% | -0.46% | 0.23% | -3.14% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.67 | 2.95 | 4.36 | 4.02 | NA |
Estimate | 3.45 | 3.16 | 3.99 | 3.77 | NA |
Difference | 0.22 | -0.21 | 0.37 | 0.25 | 0.16 |
Surprise | 6.38% | -6.65% | 9.27% | 6.63% | 3.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more